Chapter 191 Patent Infringement?
Xiao Ming returned to Praruo Village.
Before the completion of the industrial park, Hanruo Village was the largest base of Pangu Technology.
So far, except for the Yigou Division and the System Division in Guangyao Building, the rest of the departments are in Pranya Village.
Gao Siqi reported the specific situation to Xiao Ming, which sounded more serious than expected.
Even if Pangu Technology successfully treated a patient, even if Pangu Technology published a paper, from the perspective of clinical treatment effect, the appearance of suppressed gene therapy technology and nivolumab treatment is almost the same.
In particular, waiting for cancer cells to die, which is the most typical manifestation of PD-1 inhibition treatment.
Gao Siqi said: "On the surface, the patient's condition and indicators of successful treatment are similar, so Squibb determined that we were misappropriating his intellectual property. ”
Xiao Ming said helplessly: "Judging from the final indicators, if nivolumab really has a significant effect on patients, then there is indeed no difference between the two, because everyone's indicators are close to normal, but in essence, the two are absolutely different." ”
"What if we don't accept the lawyer's letter?"
"Will be prosecuted. Gao Siqi said: "Xia Guo has joined 26 international intellectual property convention organizations, including the Convention Establishing the World Intellectual Property Organization, and high-tech intellectual property rights similar to those in the medical field are strictly protected in the country. ”
In addition to intellectual property rights, the implementation of Guibao company cares more about the market profit of 100 billion meters of knife.
The cost of treatment with nivolumab is 40,000 yuan per month and 480,000 yuan a year.
Based on a patient's five-year life expectancy, the patient would have spent 2.4 million yuan.
And what about Pangu Technology's treatment technology? About 300,000 people can be restored to healthy people.
Moreover, the therapeutic effect of targeted drugs depends on the probability, and there is no 100% certainty.
Patients are not stupid and will definitely seek treatment from Pangu Technology.
In the foreseeable future, when suppressive gene therapy conquers more cancers, there will be no room for pharmaceutical companies such as Bristol-Myers Squibb and Bayer to develop targeted therapy drugs.
All the patients and treatment costs will flow to Xia Guo and to the medical institutions centered on Pangu Technology.
The global medical center has shifted to the Xia Kingdom, which is the most terrible and worrying thing for Western society.
"If the other party sues us, no matter what the final truth is, the clinical treatment qualification for the use of our suppressed gene expression technology will be suspended internationally. ”
"Internationally?" Xiao Ming asked.
"Yes, internationally. This will allow us to vigorously promote this technology into the clinic. ”
Among the 26 related intellectual property rights and patents, it is agreed that if there is a dispute between the two parties, the relevant patented products of both parties will be stopped at the same time in the intellectual property member countries, and the patented products will be continued to be used by the two parties after an agreement or final arbitration.
"What about in China?" Xiao Ming is more concerned about domestic issues, after all, the promotion of technology in the international community is still relatively far away.
Gao Siqi's words made Xiao Ming feel that her brain was a little short-circuited, and she said: "For other countries, Xia Guo is also a member of international organizations, so the prohibition order is effective for Xia Guo. ”
Xiao Ming: "...... It's ruthless. ”
Gao Siqi has studied this comparison and said: "The rules are set by people, usually the other party does not have definite evidence to prove that we infringe, we can still use the technology in the clinic in our country, but we have to fight a war of words." ”
Xiao Ming said: "It is indeed a good thing for Pangu Technology, and we will also take this opportunity to prove to the world that the field of Xia Guo medicine has been in the leading field in the world." ”
Gao Siqi said: "In fact, as long as it depends on the attitude of Jiangcheng University and relevant departments. ”
Gao Siqi analyzed: "Now Xia Guo is in line with international standards in the field of intellectual property, and hopes to establish an image of protecting intellectual property rights to the world. Xia Guo hopes to throw away the hat of theft and copycat in the world, so that Xia Guo can introduce more and more advanced technology. ”
Internationally, the accusations of the countries led by the United States and the European Union against Xia Guo are stealing the intellectual property rights of other countries.
The reason for the embargo is that Xia does not respect the intellectual property rights of science and technology, and the technology embargo is also the reason for the huge trade deficit between the United States and Xia.
Xia Guo now wants to show everyone that he also respects intellectual property rights, but in fact, he doesn't know that the discrimination of Xia Guo by the international community is innate, and no matter how hard you try, you can't change the perception of the United States and Europe about you.
Xiao Ming said: "When we develop science and technology, we don't need to care about the feelings of the international community, what we care about is the feelings of patients. ”
"So?" Gao Siqi said, "ignore it?"
"Of course, don't bother, we don't fight, whether it's Squibb or the United States, if there is really any objection to our technology, then use evidence to speak. ”
Xiao Ming sneered and said: "We are not opposed to treating the patients of the United States, if the people of the United States set up obstacles for us, then it is only the ordinary people of the United States who are injured." ”
Gao Siqi said: "Yes, we develop our technology and treat the people of the Xia Kingdom, what is the matter with these Mi people!"
In front of Xiao Ming, Gao Siqi tore up the other party's lawyer's letter.
Sure enough, two days later, Squibb took further steps.
First, they published an article in the New York Times that pointed the finger at Pangu Technology's plagiarism and gave a whole bunch of examples.
For example, five years ago, Squibb successfully used nivolumab to treat liver cancer patients, such as the color ultrasound index and blood index of patients using nivolumab are similar to the indicators announced by Pangu Technology using inhibitory gene expression therapy.
At the same time, Squibb sued Pangu Technology in a local court in New York, demanding that Pangu Technology immediately prohibit the use of inhibition gene expression therapy to treat patients, apologize to Squibb, and compensate Squibb Company 1 billion meters in accordance with the relevant provisions of intellectual property infringement!
This is quite excessive, which is equivalent to Squibb Company asking Mi Guo to use the local laws of Mi Guo to adjudicate a Xia Guo company!
This seemingly arrogant request is actually the consistent method of the people of the United States, replacing the international law with the domestic law of the United States, and even replacing the law of the Xia Kingdom.
At the beginning, Xia Guo companies such as Huawei and the center suffered such treatment.
Things are really as Squibb expected, and the FDA of the United States raised serious concerns to the relevant departments of Xia Guo and asked the Affiliated Hospital of Jiangcheng University to stop using suppressed gene expression therapy to treat patients.
At the same time, the New York court formally accepted the case.
.。 m.